Publications by authors named "J E Staddon"

Isolated testicular involvement in pediatric lymphoma is rare and poses diagnostic challenges. In this study, the case of an isolated testicular B-lymphoblastic lymphoma in a 9-year-old boy is discussed with an emphasis on the difficulties in diagnosing and treating such an unusual presentation. This example illustrates the importance of considering lymphoblastic lymphoma in the differential diagnosis of an unidentified source of testicular enlargement.

View Article and Find Full Text PDF
Article Synopsis
  • External innovation in the pharmaceutical sector is key for research and development, focusing on collaboration to boost innovation and reduce costs and risks, particularly in tackling neurodegenerative diseases.
  • The Eisai-University College London (UCL) partnership serves as a case study, showcasing effective industry-academic collaboration for drug discovery.
  • Over the first decade, seven projects were initiated, with the first – a new anti-tau antibody for Alzheimer’s disease – progressing to clinical trials, highlighting the success of this collaborative approach.
View Article and Find Full Text PDF

Glucocerebrosidase (GCase) is a lysosomal enzyme encoded by the GBA1 gene, loss of function variants of which cause an autosomal recessive lysosomal storage disorder, Gaucher disease (GD). Heterozygous variants of GBA1 are also known as the strongest common genetic risk factor for Parkinson's disease (PD). Restoration of GCase enzymatic function using a pharmacological chaperone strategy is considered a promising therapeutic approach for PD and GD.

View Article and Find Full Text PDF

Mitochondrial dysfunction and aberrant mitochondrial homeostasis are key aspects of Parkinson's disease (PD) pathophysiology. Mutations in PINK1 and Parkin proteins lead to autosomal recessive PD, suggesting that defective mitochondrial clearance via mitophagy is key in PD etiology. Accelerating the identification and/or removal of dysfunctional mitochondria could therefore provide a disease-modifying approach to treatment.

View Article and Find Full Text PDF

The atomistic rationalization of the activity of transition metal oxides toward oxygen electrocatalysis is one of the most complex challenges in the field of electrochemical energy conversion. Transition metal oxides exhibit a wide range of structural and electronic properties, which are acutely dependent on composition and crystal structure. So far, identifying one or several properties of transition metal oxides as descriptors for oxygen electrocatalysis remains elusive.

View Article and Find Full Text PDF